EV/EBITDA
-3.13
0.000.00%
Tue, 07 Jan 2025 00:19:42 GMT
Summary:
BioNexus Gene Lab EV/EBITDA is currently -3.13, unchanged from the previous trading day. Over the past year, it has dropped by -1.77 (-130.15%). BGLC EV/EBITDA is now -102.77% below its all-time high of 113.05.BGLC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | 0.0% |
1 m1 month | -83.0% |
3 m3 months | +39.0% |
6 m6 months | -104.6% |
ytdytd | -421.7% |
1 y1 year | -130.2% |
5 y5 years | - |
BGLC EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -0.14 | -2135.7% | -5.02 | +37.6% |
3 m | 3 months | -0.14 | -2135.7% | -5.13 | +39.0% |
6 m | 6 months | -0.14 | -2135.7% | -5.34 | +41.4% |
1 y | 1 year | -0.14 | -2135.7% | -5.49 | +43.0% |
3 y | 3 years | 113.05 | -102.8% | -206.21 | +98.5% |
5 y | 5 years | 113.05 | -102.8% | -206.21 | +98.5% |
alltime | all time | 113.05 | -102.8% | -206.21 | +98.5% |
BioNexus Gene Lab EV/EBITDA History
Date | Value |
---|---|
2025 | -3.13(+421.7%) |
2024 | -0.60(-57.1%) |
Date | Value |
---|---|
2023 | -1.40(-97.8%) |
2022 | -62.92(-358.4%) |
2021 | 24.35 |
FAQ
- What is BioNexus Gene Lab EV/EBITDA?
- What is the all time high EV/EBITDA for BioNexus Gene Lab?
- What is BGLC EV/EBITDA year-to-date change?
- What is BioNexus Gene Lab EV/EBITDA year-on-year change?
What is BioNexus Gene Lab EV/EBITDA?
The current EV/EBITDA of BGLC is -3.13
What is the all time high EV/EBITDA for BioNexus Gene Lab?
BioNexus Gene Lab all-time high EV/EBITDA is 113.05
What is BGLC EV/EBITDA year-to-date change?
BioNexus Gene Lab EV/EBITDA has changed by -2.53 (-421.67%) since the beginning of the year
What is BioNexus Gene Lab EV/EBITDA year-on-year change?
Over the past year, BGLC EV/EBITDA has changed by -1.77 (-130.15%)